K252696

Substantially Equivalent

LEGACY

Applicant: Phasor Health, LLC
Product code: HBG
Advisory panel: Neurology
Date received: 2025-08-27
Decision date: 2025-11-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Houston, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.